In The News

In Food and Drug Law Institute Update Magazine, Attorneys Track Drug and Device Enforcement During COVID-19

Practices: Life Sciences, FDA Regulatory, Health Care, Digital Health, Litigation

To protect consumers from fraudulent medical products during the COVID-19 pandemic, the U.S. Food and Drug Administration launched “Operation Quack Hack.” Similarly, the Department of Justice has prioritized the investigation and prosecution of fraudulent or otherwise unfair practices related to COVID-19.

A Food and Drug Law Institute Update magazine article reviews key COVID-19-related DOJ and FDA enforcement actions to date, makes predictions regarding what the next wave of federal government enforcement may include, and recommends best practices for ensuring compliance with FDA requirements for the duration of the pandemic and beyond.

The article was authored by life sciences regulatory & compliance counsel Beth Weinman and associates Joshua Oyster and Meighan Parker (all of Washington, D.C.).

Distributed with the permission of FDLI Update magazine

Cookie Settings